Abstract:
Thyronamine derivatives and analogs, methods of using such compounds, and pharmaceutical compositions containing them are disclosed. Methods of preparing such compounds are also disclosed.
Abstract:
There is provided a liquid filter comprising a filter vessel having a removable cover, a fluid inlet, an engagement lip for a filter and a fluid outlet, an open top, fluid impermeable sidewalls, and a fluid outlet at a bottom of the insert. Into the filter vessel is inserted a water impermeable insert having an insert lip engageable in a sealing relationship with the filter vessel engagement lip. A single cartridge filter is inserted within the cartridge filter insert having a generally solid top surface, a bottom fluid outlet sealingly engageable with the insert outlet and a filter material. The cartridge filter top surface forms a weir for diverting fluid to be filtered toward an annular opening created between the filter cartridge and the insert, the annular opening having a cross sectional area, which generally is from 25 to 100% of the cross sectional area of the filter cartridge outlet opening.
Abstract:
Thyronamine derivatives and analogs, methods of using such compounds, and pharmaceutical compositions containing them are disclosed. Methods of preparing such compounds are also disclosed.
Abstract:
The invention provides non-steroidal ligands for the glucocorticoid receptor, methods for making non-steroidal ligands of the glucocorticoid receptor, compositions of non-steroidal ligands of the glucocorticoid receptor and methods of using non-steroidal ligands and compositions of non-steroidal ligands of the glucocorticoid receptor for treating or preventing diseases (e.g., obesity, diabetes, depression, neurodegeneration or an inflammatory disease) associated with glucocorticoid binding to the glucocorticoid receptor.
Abstract:
The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.
Abstract:
The invention provides non-steroidal ligands for the androgen receptor, methods for making non-steroidal ligands of the androgen receptor, compositions of non-steroidal ligands of the androgen receptor and methods of using non-steroidal ligands and compositions of non-steroidal ligands of the androgen receptor for treating or preventing diseases (e.g., prostate cancer) associated with androgen binding to the androgen receptor.
Abstract:
Thyronamine derivatives and analogs, methods of using such compounds, and pharmaceutical compositions containing them are disclosed. Methods of preparing such compounds are also disclosed